IMPROVE MEDICAL INSTRUMENTS CO., LTD. Financials Improve Medical Instruments Co., Ltd.
Equities
300030
CNE100000JL3
Advanced Medical Equipment & Technology
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.88 CNY | +6.59% |
|
-10.19% | -49.94% |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 1,590 | 2,202 | 3,798 | 3,293 | 2,130 | 2,396 |
| Enterprise Value (EV) 1 | 1,848 | 2,422 | 3,969 | 3,472 | 2,333 | 2,559 |
| P/E ratio | -11.7 x | 89.1 x | 23.2 x | 178 x | -10.8 x | -38.8 x |
| Yield | - | - | 0.26% | 0.38% | - | - |
| Capitalization / Revenue | 2.89 x | 3.83 x | 4.13 x | 4.12 x | 3 x | 3.72 x |
| EV / Revenue | 3.36 x | 4.21 x | 4.32 x | 4.34 x | 3.28 x | 3.97 x |
| EV / EBITDA | 95.5 x | 33.5 x | 28.1 x | 45.8 x | -108 x | 1,324 x |
| EV / FCF | -52.2 x | 1,395 x | 603 x | 78.6 x | -239 x | 224 x |
| FCF Yield | -1.92% | 0.07% | 0.17% | 1.27% | -0.42% | 0.45% |
| Price to Book | 1.96 x | 2.63 x | 3.8 x | 3.29 x | 2.72 x | 3.31 x |
| Nbr of stocks (in thousands) | 308,796 | 308,796 | 308,796 | 309,187 | 309,187 | 309,187 |
| Reference price 2 | 5.150 | 7.130 | 12.30 | 10.65 | 6.890 | 7.750 |
| Announcement Date | 4/25/19 | 3/6/20 | 4/20/21 | 4/24/22 | 4/26/23 | 4/26/24 |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 550 | 575.1 | 919.2 | 799.8 | 710.8 | 644.6 |
| EBITDA 1 | 19.36 | 72.37 | 141 | 75.86 | -21.65 | 1.933 |
| EBIT 1 | -18.83 | 36.73 | 103.5 | 35.21 | -60.91 | -33.5 |
| Operating Margin | -3.42% | 6.39% | 11.26% | 4.4% | -8.57% | -5.2% |
| Earnings before Tax (EBT) 1 | -144.5 | 37 | 165.1 | 23.84 | -214.3 | -43.06 |
| Net income 1 | -136.8 | 26.02 | 162.5 | 18.57 | -198.3 | -63.2 |
| Net margin | -24.87% | 4.53% | 17.68% | 2.32% | -27.9% | -9.8% |
| EPS 2 | -0.4400 | 0.0800 | 0.5300 | 0.0600 | -0.6400 | -0.2000 |
| Free Cash Flow 1 | -35.42 | 1.736 | 6.578 | 44.15 | -9.78 | 11.4 |
| FCF margin | -6.44% | 0.3% | 0.72% | 5.52% | -1.38% | 1.77% |
| FCF Conversion (EBITDA) | - | 2.4% | 4.66% | 58.2% | - | 589.9% |
| FCF Conversion (Net income) | - | 6.67% | 4.05% | 237.78% | - | - |
| Dividend per Share | - | - | 0.0320 | 0.0400 | - | - |
| Announcement Date | 4/25/19 | 3/6/20 | 4/20/21 | 4/24/22 | 4/26/23 | 4/26/24 |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 257 | 221 | 171 | 179 | 202 | 163 |
| Net Cash position 1 | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | 13.29 x | 3.051 x | 1.212 x | 2.361 x | -9.34 x | 84.16 x |
| Free Cash Flow 1 | -35.4 | 1.74 | 6.58 | 44.2 | -9.78 | 11.4 |
| ROE (net income / shareholders' equity) | -15.8% | 3.16% | 17.7% | 1.94% | -20.9% | -7.61% |
| ROA (Net income/ Total Assets) | -0.72% | 1.52% | 3.98% | 1.23% | -2.25% | -1.4% |
| Assets 1 | 18,934 | 1,711 | 4,083 | 1,506 | 8,812 | 4,504 |
| Book Value Per Share 2 | 2.630 | 2.710 | 3.240 | 3.230 | 2.540 | 2.340 |
| Cash Flow per Share 2 | 0.7600 | 0.6400 | 0.7000 | 1.120 | 0.7100 | 0.6900 |
| Capex 1 | 50.4 | 54.4 | 56.8 | 71.1 | 58 | 43.7 |
| Capex / Sales | 9.16% | 9.47% | 6.18% | 8.88% | 8.17% | 6.78% |
| Announcement Date | 4/25/19 | 3/6/20 | 4/20/21 | 4/24/22 | 4/26/23 | 4/26/24 |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -49.94% | 166M | |
| +9.55% | 222B | |
| +14.41% | 195B | |
| +24.02% | 148B | |
| +33.92% | 113B | |
| +4.18% | 66.45B | |
| +12.92% | 53.11B | |
| +3.16% | 50.03B | |
| -4.32% | 38.8B | |
| -1.99% | 34.85B |
- Stock Market
- Equities
- 300030 Stock
- Financials Improve Medical Instruments Co., Ltd.
